Additionally, it has been demonstrated that the MEK5/ERK5 axis regulates lipid metabolism, including the mevalonate pathway, which is responsible for cholesterol synthesis in SCLC. The gene discussed is MAP2K5; the disease is small cell lung carcinoma.